INVESTABOT
Equity Research
XNAS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-09-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-09-14. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-09-10. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-08-27. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-08-20. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-08-12. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-08-14. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-07-31. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-07-20. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-07-06. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-06-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-06-03. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-06-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-05-12. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-05-21. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 9 unique sellers · 10 accumulating - 2 trimming - 2 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 28, 2026 | Stern Sadie | EVP Chief People & Culture Off | SELL | -2,565 | $86 | ~$0.2M |
| September 15, 2026 | Brown Michael Jon | EVP Chief Legal Compliance Off | SELL | -1,700 | $84 | ~$0.1M |
| September 15, 2026 | Augustinos Nicholas | — | SELL | -6,539 | $84 | ~$0.5M |
| September 14, 2026 | Augustinos Nicholas | — | SELL | -1,550 | $84 | ~$0.1M |
| September 10, 2026 | Sylvain Jereme M | EVP, Chief Financal Officer | SELL | -3,638 | $83 | ~$0.3M |
| September 10, 2026 | Boehnlein Glenn S | — | GRANT | 5,841 | — | — |
| August 27, 2026 | Stern Sadie | EVP Chief People & Culture Off | SELL | -2,565 | $88 | ~$0.2M |
| August 22, 2026 | Leach Jacob Steven | President, CEO, and Director | TAX_WITHHOLD | -1,451 | $92 | ~$0.1M |
| August 22, 2026 | Sylvain Jereme M | EVP, Chief Financal Officer | TAX_WITHHOLD | -1,451 | $92 | ~$0.1M |
| August 22, 2026 | Brown Michael Jon | EVP Chief Legal Compliance Off | TAX_WITHHOLD | -1,451 | $92 | ~$0.1M |
| August 22, 2026 | Stern Sadie | EVP Chief People & Culture Off | TAX_WITHHOLD | -1,451 | $92 | ~$0.1M |
| August 20, 2026 | Sayer Kevin R | Executive Chair | SELL | -19,308 | $90 | ~$1.7M |
| August 20, 2026 | Sayer Kevin R | Executive Chair | SELL | -7,351 | $91 | ~$0.7M |
| August 20, 2026 | Sayer Kevin R | Executive Chair | SELL | -97 | $91 | ~$9K |
| August 14, 2026 | Brown Michael Jon | EVP Chief Legal Compliance Off | SELL | -1,700 | $92 | ~$0.2M |
| August 12, 2026 | Augustinos Nicholas | — | GIFT | -1,075 | — | — |
| August 12, 2026 | Heller Bridgette P | — | SELL | -1,012 | $88 | ~$89K |
| August 3, 2026 | Foletta Mark G | — | SELL | -2,000 | $85 | ~$0.2M |
| July 31, 2026 | Foletta Mark G | — | SELL | -2,000 | $80 | ~$0.2M |
| July 20, 2026 | Sayer Kevin R | Executive Chair | SELL | -26,756 | $76 | ~$2.0M |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| September 28, 2026 | Sadie Stern | — | 2,565 | SEC |
| September 15, 2026 | Augustinos Nicholas | — | 6,539 | SEC |
| September 15, 2026 | Michael Brown | — | 1,700 | SEC |
| September 14, 2026 | Augustinos Nicholas | — | 1,550 | SEC |
| September 10, 2026 | Jereme Sylvain | — | 3,638 | SEC |
| August 27, 2026 | Sadie Stern | — | 2,565 | SEC |
| August 20, 2026 | Kevin R Sayer | — | 26,756 | SEC |
| August 14, 2026 | Michael Brown | — | 1,700 | SEC |
| August 12, 2026 | Heller Bridgette P | — | 1,012 | SEC |
| August 3, 2026 | Foletta Mark G | — | 2,000 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| September 10, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 99,324,365 | ~$4.0B | — | August 13, 2024 |
| Vanguard Group | 49,074,378 | ~$3.3B | — | January 29, 2026 |
| BlackRock | 130,943,377 | ~$2.7B | — | February 12, 2026 |
| BlackRock | 181,839,137 | ~$2.7B | 18.5% | August 7, 2026 |
| BlackRock | 153,459,371 | ~$2.6B | 17.2% | May 13, 2026 |
| State Street | 50,705,806 | ~$1.3B | 13.8% | August 7, 2026 |
| State Street | 44,718,554 | ~$1.2B | — | February 13, 2026 |
| State Street | 44,559,847 | ~$1.2B | -0.3% | May 15, 2026 |
| JP Morgan Chase | 25,882,101 | ~$442.1M | — | February 11, 2026 |
| JP Morgan Chase | 27,476,470 | ~$397.8M | 6.2% | May 13, 2026 |
| Morgan Stanley | 7,131,282 | ~$349.1M | 7.8% | August 13, 2026 |
| Morgan Stanley | 6,722,646 | ~$338.2M | — | May 27, 2026 |
| Morgan Stanley | 6,617,044 | ~$318.1M | -1.6% | May 15, 2026 |
| Goldman Sachs | 4,107,916 | ~$276.7M | 12.1% | August 14, 2026 |
| DE Shaw | 4,145,568 | ~$275.1M | — | February 17, 2026 |
| Citadel Advisors | 92,904,567 | ~$270.1M | 131.2% | August 14, 2026 |
| JP Morgan Chase | 27,765,095 | ~$255.5M | 1.1% | August 12, 2026 |
| Goldman Sachs | 3,767,447 | ~$250.0M | — | March 25, 2026 |
| Goldman Sachs | 3,666,035 | ~$230.2M | -2.7% | May 15, 2026 |
| AQR Capital | 3,237,720 | ~$218.1M | 49.0% | August 14, 2026 |